TENTRILLO Canadian Trademark Information
Medicines for humans and animals, serums, test kits, diagnostics for medical purposes and therapeutics, namely medicines for treating cardiovascular illnesses, namely hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for the treatment of immunological diseases, namely autoimmune diseases, namely rheumatoid arthritis, polyarthritis, Crohn's disease, Lupus erythematosus, and multiple sclerosis; medicines for treating skin diseases, namely warts, genital warts, Bowen's disease, aktinic keratosis, seborrheic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes; medicines for treating tumourous diseases, namely neuronal cancer, glioma, astrocytoma, carcinoma of the colon, ovarian carcinoma, cervical carcinoma, carcinoma of the prostate, basal cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck cancer, hepatocellular carcinoma, lung cancer, pancreatic cancer, and renal cancer.
Perfect for these industries
Words that describe this mark
medicines humans animals serums test kits diagnostics medical purposes therapeutics medicines treating cardiovascular illnesses hyperlipidaemia coronary heart diseases cardiac insufficiency medicines treatment immunological diseases autoimmune diseases rheumatoid arthritis
Abandonment Notice!
On Wednesday, June 2, 2010,
status on the TENTRILLO
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Monday, June 23, 2003, a canadian trademark registration was filed for
TENTRILLO by MediGene AG *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1182382.
The current status of this trademark filing is Interruption of proceeding.
The correspondent listed for
TENTRILLO is
BORDEN LADNER GERVAIS LLP of *********, **********, ***** ****
The TENTRILLO
trademark is filed in the description of
Medicines for humans and animals, serums, test kits, diagnostics for medical purposes and therapeutics, namely medicines for treating cardiovascular illnesses, namely hyperlipidaemia, coronary heart diseases and cardiac insufficiency; medicines for the treatment of immunological diseases, namely autoimmune diseases, namely rheumatoid arthritis, polyarthritis, Crohn's disease, Lupus erythematosus, and multiple sclerosis; medicines for treating skin diseases, namely warts, genital warts, Bowen's disease, aktinic keratosis, seborrheic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes; medicines for treating tumourous diseases, namely neuronal cancer, glioma, astrocytoma, carcinoma of the colon, ovarian carcinoma, cervical carcinoma, carcinoma of the prostate, basal cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck cancer, hepatocellular carcinoma, lung cancer, pancreatic cancer, and renal cancer.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information